Global Database of CAR-T Cell Therapy Companies, 2026
[Just Updated for 2026]
CAR-T cell therapy is a treatment that involves modifying a patient's T cells to recognize and attack cancer cells.
Since the first historic CAR-T approvals in 2017, seven products have been approved in the U.S., including: Kymriah, Yescarta, Tecartus, Breyanzi, Abecma, Carvykti, and Aucatzyl. Globally, at least 13 CAR-T cell therapies have achieved regulatory approval, including seven from the U.S., four from China, and two from India.
These historic approvals have driven the CAR-T market to staggering new heights.
To track the competitors who compose this rapidly expanding marketplace, BioInformant has released a database of all known CAR-T cell therapy companies—currently 259 worldwide.
As you can imagine, it takes our analysts hundreds of hours of research to uncover these companies from across the globe and requires the translation of sites and clinical trial programs across dozens of languages. Thankfully, we have a talented, multilingual team who is up to the task.
You can use this database to:
- Identify global competitors across the CAR-T marketplace
- Reveal preclinical and clinical programs supporting CAR-T development
- Spot regions that are “hotspots” for CAR-T companies
- Identify potential partners and collaborators
- Become immediately informed, without the need for research, time, or effort
Would you benefit from knowing all known CAR-T market competitors worldwide, including their technologies under development, disease targets, and CAR-T involvement?
If so, access the information you need instantly and effortlessly.
For 48 hours only, you can claim this 2026 database for an unusual $150 off:
Remember to act fast, because this offer expires soon.
Be Great,
The BioInformant Team
p.s. We're running sales on several other products this week too.
|
![[Just Updated for 2026] Global Database of CAR-T Cell Therapy Companies, 2026 | Since the first historic...](https://m.gr-cdn-1.com/getresponse-H83W/photos/bb565ef4-9b1d-4514-89fc-4d375aa56d4e.png|600|314|600|314|0|0|1)